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Abstract  Primary  aortoesophgeal  ﬁstulas  (AEF)  are  a  rare  but  life-threatening  condition
because  of  substantial  hemorrhage,  requiring  fast  treatment  to  ensure  patient  survival.  We
report a  case  of  a  69-year-old  male  with  diagnosis  of  squamous  cell  carcinoma  of  the  esoph-
agus who  suffered  an  episode  of  hematemesis  and  hemorrhagic  shock.  Gastrointestinal  (GI)
endoscopy  revealed  an  ulcerated  lesion  with  pulsatile  hemorrhage.  CT-scan  conﬁrmed  the  diag-
nosis of  AEF.  A  stent-graft  was  placed  in  the  descending  aorta  to  control  bleeding,  and  2  days
later an  esophageal  stent  was  deployed  to  reduce  risk  of  aortic  graft  infection.  The  patient
was discharged  13  days  after  admission  and  had  no  other  episode  of  GI  bleeding  in  a  6-month
follow-up  period.  TEVAR  may  be  used  as  a  palliative  or  bridge  treatment  of  AEF.
© 2016  Sociedade  Portuguesa  de  Angiologia  e  Cirurgia  Vascular.  Published  by  Elsevier  Espan˜a,
S.L.U. This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
PALAVRAS-CHAVE
Fístula
Fístula  aorto-esofágica  em  doente  com  neoplasia  do  esófago  --  Caso  clínicoaorto-esofágica;
Aorta;
Resumo  As  ﬁstulas  aorto-esofágicas  (FAE)  primárias  são  raras  mas  com  elevada  mortalidade
devido à  hemorragia  digestiva  substancial,  necessitando  intervenc¸ão  rápida  para  garantir  aEndoprótese  aórtica;
Stent  esofágico;
Hemorragia  digestiva
alta
sobrevivência  do  doente.  Os  autores  apresentam  um  caso  dum  homem  de  69  anos  com  carcinoma
esofágico que  teve  episódio  de  hematemeses  e  choque  hemorrágico.  A  endoscopia  digestiva  alta
mostrou lesão  ulcerada  com  hemorragia  pulsátil,  a  angioTC  conﬁrmou  o  diagnóstico  de  FAE.  Foi
colocada endoprótese  na  aorta  descendente  para  controlo  da  hemorragia;  dois  dias  depois∗ Corresponding author.
E-mail address: queiroz.sousa@gmail.com (G. Queiroz de Sousa).
ttp://dx.doi.org/10.1016/j.ancv.2016.03.003
646-706X/© 2016 Sociedade Portuguesa de Angiologia e Cirurgia Vascular. Published by Elsevier Espan˜a, S.L.U. This is an open access article
nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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foi  colocado  stent  esofágico  para  reduzir  risco  de  infecc¸ão  da  endoprótese.  O  doente  teve  alta
ao décimo  terceiro  dia,  e  não  foi  reportada  hemorragia  digestiva  nos  seis  meses  de  seguimento.
Este caso  mostra  como  o  TEVAR  pode  ser  usado  como  tratamento  paliativo  ou  temporário  duma
FAE.
© 2016  Sociedade  Portuguesa  de  Angiologia  e  Cirurgia  Vascular.  Publicado  por  Elsevier  Espan˜a,
S.L.U. Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
F
h
(
T
i
a
c
l
w
n
m
m
D
T
f
t
l
a
w
gIntroduction
A  primary  aortoesophageal  ﬁstula  (AEF)  is  a  communica-
tion  between  the  aorta  and  the  esophagus,  without  previous
surgery.  Being  a  rare  entity,  the  most  frequent  causes
are  thoracic  aortic  aneurysm,  foreign  body  ingestion  and
esophageal  malignancy,  being  the  thoracic  aortic  aneurysm
by  far  the  most  common  cause.1 It  is  a  life-threatening
condition  due  to  massive  upper  gastrointestinal  bleeding,
so  prompt  treatment  is  mandatory  for  patient  survival.
Here  we  report  a  case  of  primary  AEF  treated  successfully
with  a  stent-graft.
Clinical case
A  63-year-old  caucasian  male,  with  coronary  heart  disease
(NSTEMI  in  2007)  and  known  diagnosis  of  squamous  cell
carcinoma  of  the  esophagus  since  early  2014,  which  had
been  staged  T3N+M0  in  June  2014,  underwent  neoadjuvant
chemotherapy  (two  cycles  of  cisplatin  +  5-ﬂuorouracil)  and
radiotherapy  (50.4  Gy)  between  July  and  September  and  had
surgery  of  the  esophagus  scheduled  for  mid-October.
However,  in  early  October  he  was  admitted  to  the
Emergency  Department  with  fever  (39.2 ◦C)  plus  vomits
and  melena  for  3  days.  He  presented  with  hypotension
(96/59  mmHg),  and  had  a  painless  abdomen  on  observation.
Lab  results  revealed  a  hemoglobin  of  10.5  g/dL,  platelets  of
31,200/L  and  reactive  C  protein  of  15.2  mg/dL.
He  was  transferred  to  a  Medicine  Ward  and  on  the
next  day  suddenly  lost  conscience  after  an  episode  of
hematemesis.  His  hemoglobin  fell  to  6.8  g/dL.  After  ﬂuid
resuscitation,  the  patient  recovered  from  the  hemorrhagic
shock.  An  upper  gastrointestinal  endoscopy  showed  an  ulcer-
ated  middle  esophagial  neoplastic  lesion,  with  a  high  output,
pulsatile  hemorragy,  with  high  probability  of  AEF  (Fig.  1).
A  CT  angiogram  was  performed,  and  identiﬁed  the  pres-
ence  of  air  bubbles  between  the  aorta  and  the  esophagus,
with  irregularity  of  the  aortic  contour  in  this  location,  with
extravasion  of  contrast  in  the  arterial  phase  of  the  exam,
suggestive  of  AEF  (Figs.  2  and  3).
After  admission  in  the  ICU,  and  following  a  multidisci-
plinary  discussion  of  the  case,  endovascular  treatment  was
performed  with  a  Cook® Zenith  TX2  30  mm  ×  140  mm  stent
graft  deployed  in  the  descending  aorta,  beyond  the  origin
of  the  left  subclavian  artery  (Fig.  4).  Two  days  later  a cov-
ered  self-expandable  esophageal  stent  was  placed  with  the
intent  of  reducing  the  risk  of  aortic  stent  graft  infection
p
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nigure  1  Ulcerated  middle  esophageal  neoplastic  lesion,  with
igh output,  pulsatile  hemorragy.
Fig.  5).  Both  procedures  had  no  short-term  complications.
he  patient  had  no  more  episodes  of  gastrointestinal  bleed-
ng,  kept  hemodynamic  stability,  and  was  discharged  13  days
fter  admission  in  the  Hospital  Emergency  Department.
Since  then,  the  patient  kept  follow-up  in  outpatient
linic,  is  doing  prophylactic  therapy  with  amoxicillin  clavu-
anate,  and  has  had  several  re-admissions  in  Medicine  Ward
ith  difﬁcult-to-control  pain,  dysphagia  for  solid  food  but
ot  for  liquids,  and  progressive  weight  loss.  There  were  no
ore  episodes  of  gastrointestinal  bleeding  reported  in  a  6-
onth  follow-up  period.
iscussion
his  case  reports  a  life-threatening  condition  that  requires
ast  decisions  in  order  to  save  a  patient’s  life,  while  trying
o  offer  a  lasting  solution  for  the  esophageal  and  the  aortic
esions.
In  1991,  Hollander  and  Quick  published  a review  of  the
vailable  literature  regarding  AEF,  where  esophageal  cancer
as  the  third  leading  cause  of  AEF,  and  at  that  time  rapid  sur-
ical  intervention  was  recommended  as  the  only  chance  for
atient  survival,  since  all  the  cases  which  had  been  managed
n  a  conservative  way  had  died  of  exsanguination.1
After  the  introduction  of  endovascular  aortic  repair,2 a
ew  alternative  for  the  treatment  of  AEF  has  been  proposed.
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Figure  2  Irregularity  of  the  aortic  contour  with  relation  to
esophageal  wall  neoplastic  formation.
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Figure  4  Aortic  and  esophageal  stentgrafts.
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well  as  providing  sealing  of  the  ﬁstula  on  the  esophagealigure  3  Presence  of  extra-luminal  air  bubbles  between  the
orta and  the  esophagus.
In  these  patients  there  is  another  challenge,  infection.
ne  must  consider  that  infection  is,  by  principle,  present
n  this  group  of  patients3,4 which  makes  open  surgery  and
ebridement  of  infected  tissues  the  treatment  of  choice
or  these  patients.  The  commonly  used  technique  for  open
epair  of  AEF  requires  left  thoracotomy  and  aortic  replace-
ent  or  even  extra-anatomic  bypass  in  cases  of  serious
nfection.5 However,  open  surgery  is  related  with  high-
ortality  rate  in  this  group  of  patients,1 although  exact
ortality  rates  are  not  available  in  literature  due  to  the
ow  number  of  cases  of  AEF.
This  is  why  endovascular  exclusion  of  thoracic  aortic  ﬁs-
ulas  with  TEVAR  may  deﬁnitely  have  a  role,  especially  in  the
apid  control  of  hemorrhage  in  often  physically  and  physio-
ogically  fragile  patients.6
s
OFigure  5  Covered  self-expandable  esophageal  stent.
In  the  literature  there  are  only  small  series  or  case
eports  published  describing  the  use  of  TEVAR  in  the
anagement  of  AEF,  but  this  technique  should  be  consid-
red  as  a  palliative  treatment,7 or  a  ‘‘bridge’’  until  the
atient  is  healthy  enough  to  endure  open  surgery,3,7 with
road-spectrum  antibiotherapy  to  control  infection.  Allen4
onsiders  that  TEVAR  ‘‘should  be  used  only  for  speciﬁc  indi-
ations,  such  as  infection  with  low-virulence  organisms,
bsence  of  gross  purulence,  and  high  operative  risk’’.
Moreover,  after  the  diagnosis  of  the  AEF  this  tumor  is
ow  a T4b  (unresectable),  and  staged  IIIc,  which  according
o  the  NCCN  guidelines  is  candidate  for  chemotherapy  if  the
atient  tolerates  it,  or  only  palliative  management.9
In  our  patient,  and  in  order  to  reduce  the  contact  of  the
ndograft  with  the  septic  environment  of  the  esophagus  aside,  a  self-expandable  covered  esophageal  stent  was  used.
ne  report8 describes  the  use  of  an  esophageal  stent  as  the
soph
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8Aortoesophageal  ﬁstula  in  a  patient  with  carcinoma  of  the  e
ﬁrst  means  to  tamponade  and  control  hemorrhage  from  AEF,
followed  by  TEVAR.  In  this  report,  the  patient  died  2  months
later  of  disseminated  malignancy.
Conclusion
Endovascular  management  of  urgent  cases  of  AEF  with
TEVAR  is  a  feasible  technique,  and  may  have  a  role  in  a
speciﬁc  group  of  patients,  especially  those  that  do  not  have
conditions  for  open  surgery  or  are  in  terminal  phase  of  malig-
nant  disease.
The  use  of  concomitant  esophageal  stenting  may  have  the
potential  of  reducing  the  infection  of  the  aortic  stent-graft,
but  this  needs  to  be  supported  by  other  studies.
However,  there  is  only  a  low  number  of  published  cases,
and  we  have  limited  time  of  follow-up,  so  more  evidence  is
necessary  to  evaluate  long-term  outcomes  of  this  treatment
option  for  AEF.
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